John Maraganore

Insider Reports History

Entity
Individual
Location
75 Sidney St, Cambridge, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Maraganore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 228K $42.2M $185.32 Dec 22, 2021 Direct
AGIOS PHARMACEUTICALS, INC. Director Common stock 28.5K $617K $21.64 Sep 20, 2022 Direct
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 3.13K $581K $185.32 Dec 21, 2021 by Managed Account
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 23.1K $564K $24.40 Jun 5, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (right to buy) 51.7K Dec 10, 2021 Direct
PROKIDNEY CORP. Director Director stock option (right to buy) 48.1K Jun 29, 2023 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 16K Jun 18, 2024 Direct

Insider Reports Filed by John Maraganore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Director
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
PROK PROKIDNEY CORP. Jun 29, 2023 1 $0 4 Jul 3, 2023 Director
KYMR Kymera Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Dec 31, 2022 1 $0 5 Feb 3, 2023 Director
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
PROK PROKIDNEY CORP. Jul 11, 2022 2 $0 4 Jul 13, 2022 Director
PROK PROKIDNEY CORP. Jul 11, 2022 0 $0 3 Jul 13, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 21, 2022 2 $0 4 Jun 23, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2022 2 $0 4 May 24, 2022 Director
KYMR Kymera Therapeutics, Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Director
KYMR Kymera Therapeutics, Inc. Jan 17, 2022 0 $0 3 Jan 19, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 21, 2021 4 -$1.25M 4 Dec 23, 2021 Chief Executive Officer, Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 10, 2021 8 $400K 4 Dec 14, 2021 Chief Executive Officer, Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Nov 12, 2021 7 -$5.59M 4 Nov 12, 2021 Chief Executive Officer, Director
BEAM Beam Therapeutics Inc. Nov 5, 2021 1 $0 4 Nov 8, 2021 Director
BEAM Beam Therapeutics Inc. Nov 5, 2021 0 $0 3 Nov 8, 2021 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 13, 2021 7 -$6.55M 4 Aug 16, 2021 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. May 28, 2021 3 $0 4 Jun 2, 2021 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2021 2 $0 4 May 24, 2021 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 13, 2021 9 -$4.2M 4 May 17, 2021 Chief Executive Officer, Director